Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 155,492 - -
Change - -20.69% -0.18% 2.67% 11.05% -28.63% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 163,560 160,947 157,071
Change - -20.41% 0.28% 1.92% 9.66% -26.41% -1.6% -2.41%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 22.3x 19.1x 16.4x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.14x 3.01x 2.81x
PEG - -36.9x -2x 0x -0.7x 3x 1.1x 1x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.09x 2.84x 2.65x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.25x 2.94x 2.68x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 12.1x 11x 9.86x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 14x 12.4x 11x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 18.9x 17.1x 15.1x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 5.3% 5.86% 6.61%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.549 2.718 2.858
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.86% 3.05% 3.2%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.997 4.681 5.438
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 63.8% 58.1% 52.6%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,262 54,740 58,591
EBITDA 1 12,815 12,485 10,188 10,635 11,735 13,500 14,687 15,938
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,661 13,022 14,302
Net income 1 7,071 6,933 5,723 13,402 6,524 6,923 8,285 9,226
Net Debt 1 7,801 6,891 7,783 6,509 4,407 8,068 5,455 1,580
Reference price 2 140.74 109.79 110.07 113.11 125.29 89.27 89.27 89.27
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/22/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
18.26x3.22x11.31x3.69% 103B
16.5x0.18x11.68x0.8% 57.7B
31.96x7.77x20.31x1.25% 52.27B
38.59x3.08x10.51x2.49% 42.68B
37.81x1.38x12.14x0.26% 33.35B
29.71x5.26x16.78x-.--% 28.06B
42.66x7.46x26.92x0.24% 25.36B
48.05x6.45x20.7x0.45% 21.03B
23.26x3.41x12.24x1.25% 20.61B
Average 31.87x 4.24x 15.84x 1.16% 42.67B
Weighted average by Cap. 28.16x 3.82x 14.57x 1.69%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABL Stock
  5. Valuation Abbott Laboratories